Details for 2018859241
Up to date per 26.05.2026
Actions
Details for 2018859241
Granted/Registered
European Patent
29.07.2020 A
29.03.2023 B1
20.09.2017
US
201762560901 P
A61K 48/00 20060101AFI20210525BHEP
Owner
4D Molecular Therapeutics Inc.5980 Horton Street Suite 460 Emeryville, CA 94608US
Representative
No representatives present
Inventor
KIRN, David H.5980 Horton Street Suite 460 Emeryville, CA 94608US
KOTTERMAN, Melissa5980 Horton Street Suite 460 Emeryville, CA 94608US
SCHAFFER, David5980 Horton Street Suite 460 Emeryville, CA 94608US
Information about Fees